Tazi I, Fehri S, Elghrari K, Ouazzani T, Benchemsi N
Laboratoire d'Hématologie, CHU Ibn Rochd, Casablanca, Maroc.
East Mediterr Health J. 2009 May-Jun;15(3):701-8.
We determined the prevalence of antibodies to Epstein-Barr virus (EBV) in 44 patients with systemic lupus erythematosus (SLE) and 44 healthy blood donors matched for sex and age as controls. Of the cases, 39 were women; mean age was 33 years. Four cases (9%) and 5 controls (11%) were positive for IgM anti-viral capsid antigen (VCA) (P = 0.9). All the cases were positive for IgG anti-VCA compared with 91% of the controls (P = 0.12). The mean immunity ratio for this antibody was 2.341 in cases and 1.873 in controls (P = 0.068). Forty (91%) cases were positive for IgG anti-EBNA1 (EB nuclear antigen1) compared with 42 (95%) controls (P = 0.6).
我们测定了44例系统性红斑狼疮(SLE)患者及44名年龄和性别相匹配的健康献血者作为对照中抗爱泼斯坦-巴尔病毒(EBV)抗体的流行情况。病例组中,39例为女性;平均年龄为33岁。4例(9%)病例和5名对照(11%)的IgM抗病毒衣壳抗原(VCA)呈阳性(P = 0.9)。与91%的对照相比,所有病例的IgG抗VCA均呈阳性(P = 0.12)。该抗体的平均免疫比在病例组中为2.341,在对照组中为1.873(P = 0.068)。40例(91%)病例的IgG抗EBNA1(EB核抗原1)呈阳性,相比之下,42名对照(95%)呈阳性(P = 0.6)。